Evidence map›Paper›PMID 31396497›Full record

ArticleFrontiers in pediatrics2019

Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease.

Beatrice Rivalta, Daniele Zama, Giovanni Pancaldi, Elena Facchini, Maria Elena Cantarini, Angela Miniaci, Arcangelo Prete, Andrea Pession

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Red flags to suspect inborn errors of immunity in patients with autoimmune diseasesBiomedica : revista del Instituto Nacional de Salud · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  13. Article
  14. Article
  15. Response to rituximab in children and adults with immune thrombocytopenia (ITP).Research and practice in thrombosis and haemostasis · 2021
    Article
  16. Article
  17. Article
  18. Autoimmune Hemolytic Anemia in the Pediatric Setting.Journal of clinical medicine · 2021
    Review
  19. Case Report: Post-Partum Complications ofFrontiers in pediatrics · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Beatrice RivaltaDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Daniele ZamaDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Giovanni PancaldiDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Elena FacchiniDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Maria Elena CantariniDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Angela MiniaciDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Arcangelo PreteDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Andrea PessionDepartment of Pediatrics, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
University of Bologna · ITPoliclinico S.Orsola-Malpighi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evans syndrome (ES) is a rare but challenging condition, characterized by recurrent and refractory cytopenia episodes. Recent discoveries highlighted that an appropriate diagnostic workup is fundamental to identify an underlying immune dysregulation such as primary immunodeficiencies or a rheumatological disease. We hereby describe clinical features and laboratory results of 12 pediatric patients affected by ES referred to the Pediatric Onco-Hematology Unit of Bologna. Patients experienced a median of four acute episodes of cytopenia with 9 years as median age at the onset of symptoms. In 8/12 (67%) patients an underlying etiology, primary immunodeficiencies, or rheumatological disease was identified. In 4/12 children, other immune manifestations were associated (Thyroiditis, Celiac disease, Psoriasis, Vitiligo, Myositis, Membranoproliferative Glomerulonephritis). ES remained the primary diagnosis in four patients (33%). At a median follow-up time of 4 years, 5/12 (42%) patients revealed a chronic ITP, partially responsive to second line therapy. Immunoglobulin Replacement Therapy (IRT) was effective with a good hematological values control in three patients with a secondary ES (ALPS, CVID, and a patient with Rubinstein Taybi Syndrome and a progressive severe B cell deficiency with hypogammaglobulinemia). Our experience highlights that, in pediatric patients, ES is often only the first manifestation of an immunological or rheumatological disease, especially when cytopenias are persistent or resistant to therapy, with an early-onset or when are associated with lymphadenopathy.

Indexed as

autoimmune diseasechildrenEvans syndromeimmune cytopeniasimmunological characterizationprimary immunodeficiencyrefractory cytopeniarheumatological disease

Identifiers

PMID31396497
PMCPMC6664023
OpenAlexW2962225575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.